Released evidence derived from medical trials assessing the efficacy and security of CBD in clients with gastrointestinal disorders remains scarce. That point led Dr. Camilleri and Mayo Clinic colleagues to perform a randomized managed trial investigating using CBD in patients with gastroparesis